2Sasako M, Sano T, Yamamoto S, et al. D2 lymphadenectomy alone or with para- aortic nodal dissection for gastric cancer [J]. New England Journal of Medicine, 2008, 359(5): 453-462. 被引量：1
4Tanabe K,Yoshida K,Hamai Y,et al.Clinical study of TS-1 for inoperative and recurrent gastric cancer and evaluation of long survival cases [J].Gan To Kagaku Ryoho,2005;32(8):1145 被引量：1
5Sakaguchi Y,Kabashima A,Okita K,et al.Long-term outcome of S-1 and cisplatin combination therapy in patients with advanced or recurrent gastric cancer [J].Gastric Cancer,2005;8(2):111 被引量：1
6Johira H,Yunoki S,Kawata N,et al.Results of treatment of far advanced and recurrent stomach cancer with TS-1 [J].Gan To Kagaku Ryoho,2005;32(2):195 被引量：1
7Yonemori K,Shimada Y,Goto A,et al.Retrospective analysis of clinical results and predictors of response in chemo-naive patients with advanced gastric cancer treated with S-1,an oral fluoropyrimidine derivative,as single-agent chemotherapy [J].Gastric Cancer,2004;7(4):204 被引量：1
8Shin SJ,Chun SH,Kim KO,et al.The efficacy of paclitaxel and cisplatin combination chemotherapy for the treatment of metastatic or recurrent gastric cancer:a multicenter phase Ⅱ study [J].Korean J Intern Med,2005;20(2):135 被引量：1
9Yeh KH,Lu YS,Hsu CH,et al.Phase Ⅱ study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer [J].Oncology,2005;69(1):88 被引量：1
10Cho EK,Lee WK,Im SA,et al.A phase Ⅱ study of epirubicin,cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer [J].Oncology,2005;68(4-6):333 被引量：1
